Transplantation and Cellular Therapy
Издатель: Elsevier · ISSN 2666-6367 · 97 статей
- Treatment Outcomes of Adult B-Cell Acute Lymphoblastic Leukemia with Post-Transplant Relapse in the Era of Immunotherapeutic Agents
- Neighborhood Socioeconomic Disadvantage and Distance From Treatment Center do not Impact Survival Outcomes of Patients With Non-Hodgkin Lymphoma and Multiple Myeloma Treated With CAR T-Cell Therapies
- Comment on “Early Immunosuppression as CRS Prophylaxis in Outpatient Haploidentical Transplants: A Randomized Phase II Study”
- Comment on “Increased Susceptibility to Long-Term Complications in Leukemia Survivors Who Received Hematopoietic Stem Cell Transplantation During Adolescence”
- Characterization of infections following bispecific T-cell engager therapy in hematologic malignancies
- Dose, Interval, and Context: Interpreting SOS/VOD Risk after Inotuzumab Before Second Allogeneic Transplantation
- A Comparative Analysis of Skin Responses per 2014 NIH Response Criteria and Modified 2025 NIH Skin Task Force Response Criteria in Patients With Sclerotic Chronic Graft-Versus-Host Disease
- Masthead (Purpose and Scope)
- Editorial Board
- From Evidence to Practice: Influenza Vaccination Strategies after Pediatric Allogeneic Hematopoietic Cell Transplant
- Long-term follow-up of relapsed/refractory large B-cell lymphoma patients treated with salvage immunochemotherapy
- Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis: Key Clinical Questions and Lessons from a Single-Center Experience
- Predictors of refractory CMV infection in children with haematological malignancies after allogeneic HSCT
- Prospective Multi-Institutional Validation of a Practical Eculizumab Dosing Regimen for Transplant-Associated Thrombotic Microangiopathy in Children and Young Adults
- Attainment of Prophylactic Target Posaconazole Concentrations During Admission for Allogeneic Stem Cell Transplant
- Officers and Directors of ASTCT
- Table of Contents
- Betrayed by My Marrow: Is There Something to Learn From It?
- The Bottom Line: OOS Cilta-cel in MM
- CAR T Cells Before HCT: Reassuring Safety, but Uncertain Benefit
- Challenges With Expansion of Cell and Gene Therapy: A Call for System-Level Action
- A Comprehensive Rehabilitation Framework to Help Optimize Outcomes Across the CAR-T Continuum—White Paper Report
- Beyond Conventional Chimeric Antigen Receptors: Expanding the Targetable Antigen Landscape in Chimeric Antigen Receptor-T Cell Therapy
- Chimeric Antigen Receptor-Based Cellular Therapies for Autoimmune Diseases: Immune Reset, Clinical Evidence, and Translational Boundaries
- Comparison of Carmustine-, Lomustine-, and Nitrosourea-Free Conditioning Regimens for Autologous HCT (Auto-HCT) in Lymphoma: Results From the Hematopoietic Cell Transplantation Brazilian Registry (HCTBR)
- Haploidentical Versus HLA-matched Unrelated Donors for Hematopoietic Cell Transplantation in Acute Leukemia: A Multicenter Observational Study in a Developing Country Facilitated by Collaboration Between the CIBMTR and the Brazilian Society of Cellular Therapy and Bone Marrow Transplantation (SBTMO)
- Real-World Safety, Efficacy, and Immune Recovery Following Out-of-Specification Ciltacabtagene Autoleucel in Multiple Myeloma
- Combination of Ruxolitinib and Extracorporeal Photopheresis as Third or Subsequent Line of Therapy for Steroid-dependent/Resistant Acute and Chronic GVHD
- Reduced-Toxicity Conditioning Allogeneic Hematopoietic Cell Transplantation with Once-Daily Intravenous Busulfan for Relapsed/Refractory Lymphoma: A Phase II Study
- Enhancing Rigor, Reproducibility, and Replicability in Biobehavioral Research: Expert Recommendations from the Biobehavioral Research Special Interest Group of ASTCT